• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

阿达木单抗治疗的患者接种两剂BBIBP-CorV疫苗后泛发性脓疱型银屑病发作：一例报告

Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report.

作者信息

Dayani Dorsa, Rokhafrouz Hatam, Balighi Kamran

机构信息

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Case Rep Dermatol. 2023 Apr 19;15(1):61-65. doi: 10.1159/000530074. eCollection 2023 Jan-Dec.

DOI:10.1159/000530074
PMID:37089907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10116389/
Abstract

Generalized pustular psoriasis is a possibly serious condition that can be triggered by various factors. Previous studies show a slight likelihood of disease exacerbation subsequent to COVID-19 vaccination. Here, we present the first (to the best of our knowledge) case of pustular psoriasis flare after each one of the two shots of the BBIBP-CorV (Sinopharm) vaccine despite adalimumab treatment.

摘要

泛发性脓疱型银屑病是一种可能较为严重的疾病，可由多种因素引发。既往研究表明，接种新冠病毒疫苗后疾病有轻微加重的可能性。在此，我们（据我们所知）首次报告了一例在接受阿达木单抗治疗的情况下，接种两剂BBIBP-CorV（国药集团）疫苗后每次均出现脓疱型银屑病发作的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/4936b36910e5/cde-2023-0015-0001-530074_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/d1ef06c6265b/cde-2023-0015-0001-530074_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/51591c064c05/cde-2023-0015-0001-530074_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/4936b36910e5/cde-2023-0015-0001-530074_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/d1ef06c6265b/cde-2023-0015-0001-530074_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/51591c064c05/cde-2023-0015-0001-530074_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61b/10116389/4936b36910e5/cde-2023-0015-0001-530074_F03.jpg

相似文献

1
Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report.阿达木单抗治疗的患者接种两剂BBIBP-CorV疫苗后泛发性脓疱型银屑病发作：一例报告
Case Rep Dermatol. 2023 Apr 19;15(1):61-65. doi: 10.1159/000530074. eCollection 2023 Jan-Dec.
2
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.摩洛哥王国 BBIBP-CorV（国药）新冠病毒疫苗真实世界研究的有效性。
BMC Public Health. 2022 Aug 20;22(1):1584. doi: 10.1186/s12889-022-14016-9.
3
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity.三剂 COVID-19 疫苗对两剂 BBIBP-CorV（国药）灭活疫苗接种后未能血清转化的多发性硬化症患者的安全性和免疫原性：一项初步研究。
Front Immunol. 2023 Feb 21;14:952911. doi: 10.3389/fimmu.2023.952911. eCollection 2023.
4
Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.新冠肺炎 mRNA 疫苗接种后泛发性脓疱性银屑病发作合并全身性毛细血管渗漏综合征。
J Dermatol. 2022 Apr;49(4):454-458. doi: 10.1111/1346-8138.16271. Epub 2021 Dec 3.
5
Association of Homologous and Heterologous Vaccine Boosters With SARS-CoV-2 Infection in BBIBP-CorV Vaccinated Healthcare Personnel.在接种BBIBP-CorV疫苗的医护人员中，同源和异源疫苗加强针与新冠病毒感染的关联
Cureus. 2022 Jul 27;14(7):e27323. doi: 10.7759/cureus.27323. eCollection 2022 Jul.
6
Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm.阿斯利康和科兴疫苗接种后的抗体反应比较。
Iran J Immunol. 2022 Sep;19(3):321-329. doi: 10.22034/iji.2022.94298.2300.
7
Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.COVID-19 基础-加强免疫接种的安全性和有效性：同源 BBIBP-CorV 与异源 BNT162b2 加强剂在 BBIBP-CorV 基础免疫人群中的效果。
Vaccine. 2023 Mar 17;41(12):1925-1933. doi: 10.1016/j.vaccine.2023.01.032. Epub 2023 Jan 23.
8
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.安全性、免疫原性和免疫持久性：中国两种新冠灭活疫苗加强接种的观察性队列研究。
Vaccine. 2022 Sep 16;40(39):5701-5708. doi: 10.1016/j.vaccine.2022.08.037. Epub 2022 Aug 22.
9
A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.科兴新冠疫苗接种后泛发性脓疱型银屑病发作：病例报告
Health Promot Perspect. 2021 May 19;11(2):261-262. doi: 10.34172/hpp.2021.32. eCollection 2021.
10
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy.使用同源或异源加强免疫策略，由第三剂BBIBP-CorV（国药集团）和BNT162b2（辉瑞-生物科技公司）疫苗引发的针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体和T细胞反应
Vaccines (Basel). 2022 Mar 30;10(4):539. doi: 10.3390/vaccines10040539.

引用本文的文献

1
Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy.银屑病管理中的感染风险与疫苗接种：生物治疗的考量
Psoriasis (Auckl). 2025 Apr 11;15:127-144. doi: 10.2147/PTT.S510141. eCollection 2025.
2
Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion.慢性泛发性脓疱型银屑病的管理：综述与专家意见
J Psoriasis Psoriatic Arthritis. 2025 Feb 2:24755303251318976. doi: 10.1177/24755303251318976.
3
Exploring the Chronic Nature of Generalized Pustular Psoriasis [Podcast].

本文引用的文献

1
What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature.特比萘芬诱导的急性全身性发疹性脓疱病（AGEP）的预期是什么？病例报告及文献复习。
Mycoses. 2022 Oct;65(10):918-925. doi: 10.1111/myc.13506. Epub 2022 Aug 25.
2
COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis.既往有斑块型银屑病的患者接种新冠疫苗后诱发脓疱型银屑病。
J Eur Acad Dermatol Venereol. 2022 May;36(5):e330-e332. doi: 10.1111/jdv.17918. Epub 2022 Jan 28.
3
Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine.
探索泛发性脓疱型银屑病的慢性本质 [播客]
Clin Cosmet Investig Dermatol. 2024 Nov 4;17:2487-2493. doi: 10.2147/CCID.S501061. eCollection 2024.
4
Pustular Eruption following COVID-19 Vaccination: A Narrative Case-Based Review.新型冠状病毒肺炎疫苗接种后出现的脓疱性皮疹：基于病例的叙述性综述
Vaccines (Basel). 2023 Jul 29;11(8):1298. doi: 10.3390/vaccines11081298.
新冠疫苗加重的急性泛发性脓疱型银屑病
JAAD Case Rep. 2021 Nov;17:1-3. doi: 10.1016/j.jdcr.2021.08.035. Epub 2021 Sep 9.
4
De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.接种牛津-阿斯利康新冠疫苗后新发泛发性脓疱型银屑病。
Clin Exp Dermatol. 2022 Jan;47(1):153-155. doi: 10.1111/ced.14895. Epub 2021 Sep 30.
5
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.COVID-19 疫苗在免疫介导的炎症性疾病患者中的安全性和有效性：现有证据综述。
J Am Acad Dermatol. 2021 Nov;85(5):1274-1284. doi: 10.1016/j.jaad.2021.07.054. Epub 2021 Aug 4.
6
Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.新冠病毒疫苗接种后银屑病病情加重：来自单一中心的14例报告。
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e857-e859. doi: 10.1111/jdv.17582. Epub 2021 Aug 20.
7
A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.科兴新冠疫苗接种后泛发性脓疱型银屑病发作：病例报告
Health Promot Perspect. 2021 May 19;11(2):261-262. doi: 10.34172/hpp.2021.32. eCollection 2021.
8
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.与辉瑞-生物科技公司的第二剂BNT16B2b2新冠mRNA疫苗相关的银屑病发作。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
9
Psoriasis flare after influenza vaccination in Covid-19 era: A report of four cases from a single center.新冠疫情时代流感疫苗接种后银屑病发作：来自单一中心的4例报告
Dermatol Ther. 2021 Jan;34(1):e14684. doi: 10.1111/dth.14684. Epub 2020 Dec 22.
10
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.开发一种具有强大预防 SARS-CoV-2 能力的灭活疫苗候选物，BBIBP-CorV。
Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6.